======================
Answer 1:
Newborns are considered at high risk of COVID-19 in case that they are born to mothers diagnosed with COVID-19, or have close contact with someone with probable or confirmed COVID-19, or live in or travel to the epidemic area. Clinical manifestations of infected neonates, especially preterm infants, might be nonspecific, which might include temperature instability, gastrointestinal and cardiovascular dysfunction, and dominant respiratory problems. Some severe patients could rapidly develop acute respiratory distress syndrome. All infants with suspected COVID-19 should be isolated and monitored regardless of whether or not they present with symptoms. Diagnosis of neonatal COVID-19 could be confirmed if the suspected patients have positive nucleic acid test for COVID-19 from the respiratory tract, stool or blood specimens. 4 Infants with highly suspected or confirmed COVID-19 should be referred to the designated neonatal ward. All medical staff involved should wear protective equipment. The neonatal department should be strictly stratified into transitional, quarantine, living and work areas. Infants with suspected infection should be isolated in a single room, while confirmed patients should be moved into separate rooms. The quarantine room should be equipped with an isolated air cycle system. Due to the strong infectivity of COVID-19, negative pressure isolation rooms are recommended. (Score: 0.7704)
======================
Answer 1:
Pregnant women are conventionally considered a high-risk group for the progression to severe disease or death, and a case was reported of stillbirth in the second trimester of pregnancy for a woman infected with MERS-CoV [27] . Of the antiviral drugs recommended, ribavirin is in Category X for safety in pregnant women, while lopinavir/ritonavir and type 1 interferon are in Category C. Given the lack of clinical studies on antiviral treatment in pregnant women, it is difficult to recommend these drugs. Considering the physiological adaptations to pregnancy in pregnant women, conservative treatment should be provided [28] . When treating pregnant women infected with human immunodeficiency virus (HIV), the preferred protease inhibitor is lopinavir/ritonavir [29] . Among type 1 interferons, there is evidence supporting the safe use of interferon-β1a, which is used to treat multiple sclerosis, in pregnant women. Although one report showed that the incidence of spontaneous abortion increased in pregnant women who used interferon-β1a, there was no statistically significant difference with the incidence in control individuals [30, 31] . Therefore, the use of antiviral drugs can be considered after a comparison of risks and benefits of the drugs. Possible antiviral treatment would be combination therapy with interferon-β1a and lopinavir/tironavir, but there is no case report of this being used in pregnant women with MERS. Any decision to use antiviral drugs requires the consideration of ethical issues and a consultation with an obstetric specialist. (Score: 0.7427)
======================
Answer 1:
Stephanie Vijan 1 , Katarzyna Dembek 2 , Steven Reed 3 , Nathan Slovis 4 , Ramiro Toribio 5 Septicemia is the leading cause of mortality in newborn foals. Progesterone is mainly known for its role in pregnancy; however, it is also a precursor to adrenocortical and neuroactive steroids and likely plays important functions in equine neonates. Human studies have demonstrated that progesterone modulates immunity and predisposes to inflammatory conditions. However, the mechanisms by which progesterone influences outcomes in sick foals remain unclear. The goal of our study was to measure blood concentrations of inflammatory cytokines and serum amyloid A (SAA) in healthy and hospitalized foals, and to determine their association with progesterone, severity of disease, and mortality. We hypothesized that hospitalized foals will have higher progesterone, 17 α -hydroxyprogesterone and cortisol concentrations that will be associated with the inflammatory response, disease severity and mortality. Foals (n = 62) were divided into three groups based on severity of disease (septic [n = 31], sick non-septic [SNS; n = 21], and healthy [n = 10]), and hospitalized foals (SNS and septic) were divided into two groups based on survival (survivors and non-survivors). Blood samples were collected on admission. Hormones were measured by radioimmunoassay, and cytokines by ELISA. (Score: 0.7427)
======================
Answer 1:
In the cases classified as confirmed during the pandemic influenza, we have noted a slight increase in the proportion of pregnant women who present comorbidities when compared with the general population, and in the case-fatality rate in pregnant women and also in the general population (4.04%). The severity of infection by the the influenza virus in pregnant women may be related to alterations that the gestational process triggers in women, such as the overburden of the circulation, as well as of the respiratory and immunologic systems. This group is submitted to additional care, as they routinely present better adherence to the services, including the prenatal care. As a consequence, the greater attention of health professionals regarding pregnant women may contribute to a better detection of suspected and confirmed cases leading to lower complication rates, hospitalizations and mortality in this group. (Score: 0.7420)
======================
Answer 1:
It is concluded that cardiac structure and function varied during normal pregnancy in these queens. Cardiac eccentric hypertrophy, systolic function and cardiac output increases appear to be the consequences of the hemodynamic modifications occurring during pregnancy. The assessment of maternal cardiovascular function may prove a useful screening tool to detect pregnancy complications in feline reproduction. (Score: 0.7397)